Literature DB >> 10556268

The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus.

N Sutcliffe1, A E Clarke, C Gordon, V Farewell, D A Isenberg.   

Abstract

OBJECTIVE: To determine the relationship between socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus (SLE).
METHODS: One hundred and ninety-five patients with SLE were studied at two centres in the UK (London and Birmingham). Information about sociodemographics, income, employment status, social support and satisfaction with care was obtained. Outcomes were assessed by end-organ damage, disease activity and employment status.
RESULTS: Non-Caucasian race, longer disease duration, higher disease activity and lower level of education were associated with more organ damage in SLE. More satisfaction with access to care and interpersonal aspects of care, but less satisfaction with time spent with doctors, were also associated with more damage. Very long disease duration was associated with higher disease activity. Patients with higher disease activity, lower level of education and from the Birmingham centre were more likely not to be working due to their lupus.
CONCLUSION: Race and socio-economic status, as well as clinical and psychosocial factors, determine outcome in SLE.

Entities:  

Mesh:

Year:  1999        PMID: 10556268     DOI: 10.1093/rheumatology/38.11.1130

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  26 in total

1.  Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort.

Authors:  Deborah M Levy; Christine A Peschken; Lori B Tucker; Gaëlle Chédeville; Adam M Huber; Janet E Pope; Earl D Silverman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

2.  Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus.

Authors:  Michael M Ward
Journal:  J Rheumatol       Date:  2010-04-15       Impact factor: 4.666

3.  Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.

Authors:  Julia G Harris; Kristyn I Maletta; Evelyn M Kuhn; Judyann C Olson
Journal:  Clin Rheumatol       Date:  2016-12-24       Impact factor: 2.980

4.  Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.

Authors:  Michelle Petri; Sneha Purvey; Hong Fang; Laurence S Magder
Journal:  Arthritis Rheum       Date:  2012-12

Review 5.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

6.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.

Authors:  Linda T Hiraki; Candace H Feldman; Jun Liu; Graciela S Alarcón; Michael A Fischer; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2012-08

7.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

8.  Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.

Authors:  Jinoos Yazdany; Edward H Yelin; Pantelis Panopalis; Laura Trupin; Laura Julian; Patricia P Katz
Journal:  Arthritis Rheum       Date:  2008-01-15

9.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

10.  Health care in systemic lupus erythematosus (SLE): the patient's perspective.

Authors:  E J M Zirkzee; G M Steup-Beekman; A A Schouffoer; S M Henquet; M A A Caljouw; T W J Huizinga; T P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2014-04-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.